MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0026341
Bell Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.79 Cr
▼ 6% YoY
Net profit · FY 2025
₹4.18 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹21.02 Lakh
EBITDA margin 5.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.03 Lakh
Issued & subscribed
Open charges
₹16 Lakh
Satisfied ₹75.06 Lakh
Company age
43 yrs
Est. 1983
Employees · EPFO
25
Provident fund records
About Bell Pharma Private Limited
Data last updated:
Bell Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1983PTC029667. Its GSTIN is 27AABCB1393H1ZS (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.03 Lakh. It is led by directors including Yashodhan Mangesh Shukla (Whole-Time Director) and Dhananjay Mangesh Shukla (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 119/7 2nd Floor Vimal Udyog Bhuvan Taikalwadi Road Matunga Road (West), Mumbai, Maharashtra, India – 400016.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.79 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹4.18 Lakh (net margin 1.1%) and EBITDA of ₹21.02 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bell Pharma. As per MCA filings, the company has open charges of ₹16 Lakh and satisfied charges of ₹75.06 Lakh on record. The company has 1 deal on record (1 secondary share transfer); the latest was in September 2013.
Bell Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0026341). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bellpharma.com.
Company details
CIN U99999MH1983PTC029667
Registration Number 029667
Incorporation Date 30 March 1983
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0026341
Key People
Yashodhan Mangesh Shukla Whole-Time Director Dhananjay Mangesh Shukla Whole-Time Director Sunil Damodar Paithankar Director Recognitions & Rankings of Bell Pharma
Contact details
Bell Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is bellpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address119/7 2nd Floor Vimal Udyog Bhuvan Taikalwadi Road Matunga Road (West), Mumbai, Maharashtra, India – 400016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bell Pharma Private Limited, buy the company report.
Comprehensive company report
Bell Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bell Pharma operates one associated brand: Bell Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company specializing in ophthalmic and ENT products in India. | bellpharma.com |
Business activity
The main business activity of Bell Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Bell Pharma Private Limited, buy the company report.
Financials of Bell Pharma Private Limited
FY 2025 filings availableBell Pharma Private Limited reported revenue of ₹3.79 Cr (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹3.79 Cr ▼ 6%
Net profit · FY 2025
₹4.18 Lakh margin 1.1%
EBITDA · FY 2025
₹21.02 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 9%
5 years · compounded
▼ 5%
Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bell Pharma Private Limited, buy the company report.
Board of directors of Bell Pharma Private Limited
Bell Pharma has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Damodar Paithankar | Director | 30 Mar 1983 | 43 Years 6 Months | Current |
| Yashodhan Mangesh Shukla | Whole-Time Director | 01 Oct 2010 | 16 Years 0 Months | Current |
| Uttara Damodar Paithankar | Director | 01 Jul 1994 | 32 Years 3 Months | Current |
| Dhananjay Mangesh Shukla | Whole-Time Director | 01 Oct 2010 | 16 Years 0 Months | Current |
| Mangesh Manohar Shukla | Director | 01 Jul 1994 | 32 Years 3 Months | Current |
Auditor
Bell Pharma Private Limited is audited by V. A. Tungare & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. A. Tungare & Co. | FY 2023 | 111080W |
Shareholding
The shareholding of Bell Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bell Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16 Lakh
Satisfied charges
₹75.06 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 1995 | 90375785 | Bank of India | ₹1 Lakh | Open | |
| 04 Feb 1995 | 90373652 | Bank of Baroda | ₹11 Lakh | Open | |
| 29 Jul 1983 | 90373157 | Bank of Baroda | ₹2 Lakh | Open | |
| 25 Jul 1983 | 90373153 | Bank of Baroda | ₹2 Lakh | Open | |
| 31 Mar 2000 | 90373953 | Bank of Maharashtra | ₹5.06 Lakh | Satisfied |
To see the full charge records of Bell Pharma Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Bell Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in September 2013.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Bell Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bell Pharma Private Limited has a workforce of 25 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
Employee growth
19.05%
GST
Bell Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCB1393H1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bell Pharma Private Limited, buy the company report.
Recent activity
Bell Pharma Private Limited has 5 board changes on record since 1983: 5 appointments. The latest: Dhananjay Mangesh Shukla was appointed as Whole-Time Director on 01 Oct 2010.
AGM
Bell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 31 Mar 2000 via Charge ID 90373953 with Bank Of Maharashtra was fully satisfied on 24 Aug 2012.
Charges
A charge registered on 09 Mar 1998 via Charge ID 90373842 with Bank Of Maharashtra was fully satisfied on 24 Aug 2012.
Charges
A charge registered on 08 Sep 1995 via Charge ID 90373688 with Bank Of Maharashtra was fully satisfied on 24 Aug 2012.
Charges
A charge registered on 06 Sep 1995 via Charge ID 90373687 with Bank Of Maharashtra was fully satisfied on 24 Aug 2012.
Appointed
Dhananjay Mangesh Shukla was appointed as Whole-Time Director.
Appointed
Yashodhan Mangesh Shukla was appointed as Whole-Time Director.
Charges
A charge with Bank Of Maharashtra amounted to Rs. 5.06 Lakh with Charge ID 90373953 was registered on 31 Mar 2000.
Charges
A charge with Bank Of Maharashtra amounted to Rs. 9.00 Lakh with Charge ID 90373842 was registered on 09 Mar 1998.
Charges
A charge with Bank Of Maharashtra amounted to Rs. 41.00 Lakh with Charge ID 90373688 was registered on 08 Sep 1995.
Charges
A charge with Bank Of Maharashtra amounted to Rs. 20.00 Lakh with Charge ID 90373687 was registered on 06 Sep 1995.
9 earlier events are in the company report.
Frequently asked questions
Bell Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 1983 (43+ years old) and is registered under CIN U99999MH1983PTC029667.
Bell Pharma has 5 current directors:
- Yashodhan Mangesh Shukla - Whole-Time Director
- Dhananjay Mangesh Shukla - Whole-Time Director
- Sunil Damodar Paithankar - Director
- Uttara Damodar Paithankar - Director
- Mangesh Manohar Shukla - Director
The latest financial statements of Bell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bell Pharma is 27AABCB1393H1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bell Pharma is U99999MH1983PTC029667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bell Pharma was incorporated on 30 March 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
Bell Pharma has 1 deal on record (1 secondary share transfer); the latest was in September 2013.
Dhananjay Mangesh Shukla was appointed as Whole-Time Director on 01 Oct 2010. Yashodhan Mangesh Shukla was appointed as Whole-Time Director on 01 Oct 2010. Mangesh Manohar Shukla was appointed as Director on 01 Jul 1994. Bell Pharma has 5 board changes on record in total.
Yes, Bell Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0026341).
Bell Pharma can be reached through the website bellpharma.com. Its registered office is in Mumbai, Maharashtra, India.